Trifluoperazine 2HCl: A Benchmark Dopamine D2 Receptor Inhibitor for Neuropharmacology and Immunology Research

Executive Summary: Trifluoperazine 2HCl is a research-grade dopamine D2 receptor antagonist with an IC50 of 1.1 nM, enabling precise modulation of dopaminergic signaling in neuroscience assays (APExBIO). This phenothiazine derivative stimulates autophagy and ROS production in macrophages, supporting immunology and antibacterial research (Qiu et al., 2025). Its robust solubility (≥24.02 mg/mL in DMSO; ≥48 mg/mL in water; ≥7.26 mg/mL in ethanol with ultrasonication) and chemical stability (-20°C storage) ensure consistent experimental outcomes. Trifluoperazine 2HCl is widely used to investigate dopamine receptor signaling, neuropharmacology, and host-pathogen interactions. APExBIO (SKU B1397) offers validated, reproducible supply for research applications in neurology, immunology, and cancer biology.

Biological Rationale

Trifluoperazine 2HCl is a synthetic phenothiazine derivative, chemically named 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine dihydrochloride. It exhibits potent inhibition of dopamine D2 receptors, a critical target in neuropharmacology research (APExBIO). Dopamine D2 receptor antagonism is fundamental for studying neurological disorders such as schizophrenia and Parkinson's disease. In addition, phenothiazine compounds modulate innate immune cell function, specifically enhancing the antibacterial activity of macrophages by inducing autophagy and ROS (Qiu et al., 2025). Trifluoperazine 2HCl thus serves as a dual-purpose molecular tool for dissecting both neuronal and immune cell pathways.

Mechanism of Action of Trifluoperazine 2HCl

Trifluoperazine 2HCl acts primarily as a dopamine D2 receptor antagonist, binding with high affinity (IC50 = 1.1 nM) and blocking dopaminergic signaling (APExBIO). In neuronal cells, this inhibition modulates neurotransmitter release, synaptic plasticity, and downstream signaling cascades relevant to neuropsychiatric disorders (SitagliptinOnline). In macrophages, Trifluoperazine 2HCl triggers autophagosome formation and elevates ROS generation, enhancing the cell's ability to restrict intracellular bacterial pathogens (Qiu et al., 2025). This dual mechanism positions Trifluoperazine 2HCl as a valuable research probe for both dopaminergic signaling modulation and innate immune response activation.

Evidence & Benchmarks

• Trifluoperazine 2HCl inhibits dopamine D2 receptors with an IC50 of 1.1 nM, validated in vitro using radioligand binding assays (APExBIO).
• Phenothiazine compounds induce autophagy and increase ROS in macrophages, enhancing antibacterial activity in cell-based models (Qiu et al., 2025, Front Immunol).
• Trifluoperazine 2HCl exhibits high solubility: ≥24.02 mg/mL in DMSO, ≥48 mg/mL in water, ≥7.26 mg/mL in ethanol (ultrasonic assistance required) (APExBIO).
• Storage at -20°C is recommended to maintain compound stability and prevent degradation (APExBIO).
• Trifluoperazine 2HCl is a validated research tool for neuronal signaling, macrophage host-defense, and cancer biology models (NimorazoleCatalog).

Applications, Limits & Misconceptions

Trifluoperazine 2HCl is widely used in the following contexts:

• Neuropharmacology: Enables dopamine D2 receptor antagonist assays, supporting research in schizophrenia, Parkinson's disease, and dopaminergic signaling modulation (PFI-2). This article expands on previous reports by detailing the compound's dual immunomodulatory and dopaminergic effects.
• Immunology: Induces autophagy and ROS in macrophages, providing a model for host-pathogen interaction and antibacterial studies (Qiu et al., 2025).
• Cancer Biology: Used in therapeutic screening, particularly in medulloblastoma and other dopamine-receptor-expressing tumors (SitagliptinOnline). This content clarifies the compound's validated dosing and storage parameters for in vitro and in vivo models.
• Translational Research: The compound's robust solubility and stability parameters ensure reproducibility in experimental workflows (3x-Flag-Peptide). This review updates prior summaries by providing detailed chemical property data and recommended handling practices.

Common Pitfalls or Misconceptions

• Trifluoperazine 2HCl is for research use only; it is not approved for clinical or therapeutic administration in humans or animals.
• The compound does not directly eliminate bacteria; its host-directed effects depend on macrophage activation and are not universally effective against all pathogens (Qiu et al., 2025).
• Long-term storage of solutions (>1 week) at room temperature or above -20°C can lead to degradation and loss of activity (APExBIO).
• Autophagy and ROS induction by Trifluoperazine 2HCl may be cell-type specific and not generalizable to all immune cell populations.
• In vivo effects observed in animal models may not fully translate to human pathophysiology; results require contextual interpretation.

Workflow Integration & Parameters

For in vitro studies, Trifluoperazine 2HCl can be dissolved in DMSO (≥24.02 mg/mL), water (≥48 mg/mL), or ethanol (≥7.26 mg/mL with ultrasonication). Freshly prepared stock solutions are recommended for each experiment. Store dry powder at -20°C in desiccated conditions. For cell-based assays, typical working concentrations range from 10 nM to 10 μM, adjusted by endpoint and cell type (APExBIO). Avoid multiple freeze-thaw cycles to preserve compound integrity. In macrophage functional assays, co-treatment with autophagy inhibitors or ROS scavengers can be used as controls to dissect pathway specificity (Qiu et al., 2025).

Conclusion & Outlook

Trifluoperazine 2HCl (APExBIO, SKU B1397) is a highly validated dopamine D2 receptor inhibitor for research applications in neuropharmacology, immunology, and cancer biology. Its dual activity—dopaminergic antagonism and macrophage modulation via autophagy and ROS—enables multidisciplinary exploration of signaling and host defense. Continued benchmarking and workflow optimization will further enhance its utility in translational research. For complete specifications and ordering, visit the Trifluoperazine 2HCl product page.